Long-term sequential deferiprone-deferoxamineversusdeferiprone alone for thalassaemia major patients: a randomized clinical trial-Reference-Cited by-同舟云学术

Long-term sequential deferiprone-deferoxamineversusdeferiprone alone for thalassaemia major patients: a randomized clinical trial

Published:2009-04 Issue:2 Volume:145 Page:245-254
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Maggio Aurelio,Vitrano Angela,Capra Marcello,Cuccia Liana,Gagliardotto Francesco,Filosa Aldo,Romeo Maria Antonietta,Magnano Carmelo,Caruso Vincenzo,Argento Crocetta,Gerardi Calogera,Campisi Saveria,Violi Pietro,Malizia Roberto,Cianciulli Paolo,Rizzo Michele,D’Ascola Domenico Giuseppe,Quota Alessandra,Prossomariti Luciano,Fidone Carmelo,Rigano Paolo,Pepe Alessia,D’Amico Gennaro,Morabito Alberto,Gluud Christian

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2009.07609.x/fullpdf

Reference38 articles.

1. Pattern of iron chelation therapy in Egyptian beta thalassemic patients: Mansoura University Children’s Hospital experience;Abdelrazik;Hematology,2007

2. Agranulocytosis in a patient with thalassaemia major during treatment with the oral iron chelator, 1,2-dimethyl-3-hydroxypyrid-4-one;Al-Refaie;Acta Haematologica,1993

3. The effect of deferiprone (L1) and desferrioxamine on myeolopiesis using a liquid culture system;Al-Refaie;British Journal of Haematology,1994

4. Sequential use of deferiprone and desferioxamine in primary school children with thalassemia major in Turkey;Aydinok;Acta Haematologica,1999

5. A randomised controlled 1-year study of daily deferiprone plus twice weekly desferrioxamine compared with daily deferiprone monotherapy in patients with thalassemia major;Aydinok;Haematologica,2007

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination chelation therapy;Annals of the New York Academy of Sciences;2023-08-18

2. Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia;Cochrane Database of Systematic Reviews;2023-03-06

3. An evaluation of deferiprone as twice-a-day tablets or in combination therapy for the treatment of transfusional iron overload in thalassemia syndromes;Expert Review of Hematology;2023-02-01

4. Adherence to Iron Chelation Therapy among Adults with Thalassemia: A Systematic Review;Hemoglobin;2022-07-04

5. A 1-year randomized trial of deferasirox alone versus deferasirox and deferoxamine combination for the treatment of iron overload in thalassemia major;Transfusion and Apheresis Science;2019-08